319 related articles for article (PubMed ID: 25038567)
1. A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa.
Thakur R; Kumar A; Bose B; Panda D; Saikia D; Chattopadhyay P; Mukherjee AK
Biochimie; 2014 Oct; 105():149-58. PubMed ID: 25038567
[TBL] [Abstract][Full Text] [Related]
2. A new C-type lectin (RVsnaclec) purified from venom of Daboia russelii russelii shows anticoagulant activity via inhibition of FXa and concentration-dependent differential response to platelets in a Ca²⁺-independent manner.
Mukherjee AK; Dutta S; Mackessy SP
Thromb Res; 2014 Nov; 134(5):1150-6. PubMed ID: 25281435
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties and pathophysiological significance of a Kunitz-type protease inhibitor (Rusvikunin-II) and its protein complex (Rusvikunin complex) purified from Daboia russelii russelii venom.
Mukherjee AK; Mackessy SP
Toxicon; 2014 Oct; 89():55-66. PubMed ID: 24973738
[TBL] [Abstract][Full Text] [Related]
4. Two acidic, anticoagulant PLA2 isoenzymes purified from the venom of monocled cobra Naja kaouthia exhibit different potency to inhibit thrombin and factor Xa via phospholipids independent, non-enzymatic mechanism.
Mukherjee AK; Kalita B; Thakur R
PLoS One; 2014; 9(8):e101334. PubMed ID: 25118676
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Kunitz-type protease inhibitor peptide (Rusvikunin) purified from Daboia russelii russelii venom.
Mukherjee AK; Mackessy SP; Dutta S
Int J Biol Macromol; 2014 Jun; 67():154-62. PubMed ID: 24632346
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of apoptosis induction in human breast cancer MCF-7 cell by Ruviprase, a small peptide from Daboia russelii russelii venom.
Thakur R; Kini S; Kurkalang S; Banerjee A; Chatterjee P; Chanda A; Chatterjee A; Panda D; Mukherjee AK
Chem Biol Interact; 2016 Oct; 258():297-304. PubMed ID: 27613483
[TBL] [Abstract][Full Text] [Related]
7. A major phospholipase A2 from Daboia russelii russelii venom shows potent anticoagulant action via thrombin inhibition and binding with plasma phospholipids.
Mukherjee AK
Biochimie; 2014 Apr; 99():153-61. PubMed ID: 24333043
[TBL] [Abstract][Full Text] [Related]
8. A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates.
Chen M; Ye X; Ming X; Chen Y; Wang Y; Su X; Su W; Kong Y
Sci Rep; 2015 Jun; 5():10846. PubMed ID: 26035670
[TBL] [Abstract][Full Text] [Related]
9. Daboxin P, a Major Phospholipase A2 Enzyme from the Indian Daboia russelii russelii Venom Targets Factor X and Factor Xa for Its Anticoagulant Activity.
Sharma M; Iyer JK; Shih N; Majumder M; Mattaparthi VS; Mukhopadhyay R; Doley R
PLoS One; 2016; 11(4):e0153770. PubMed ID: 27089306
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant mechanism and platelet deaggregation property of a non-cytotoxic, acidic phospholipase A2 purified from Indian cobra (Naja naja) venom: inhibition of anticoagulant activity by low molecular weight heparin.
Dutta S; Gogoi D; Mukherjee AK
Biochimie; 2015 Mar; 110():93-106. PubMed ID: 25576831
[TBL] [Abstract][Full Text] [Related]
11. At-line nanofractionation with parallel mass spectrometry and bioactivity assessment for the rapid screening of thrombin and factor Xa inhibitors in snake venoms.
Mladic M; Zietek BM; Iyer JK; Hermarij P; Niessen WM; Somsen GW; Kini RM; Kool J
Toxicon; 2016 Feb; 110():79-89. PubMed ID: 26708656
[TBL] [Abstract][Full Text] [Related]
12. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of procoagulant mechanism and pathophysiological significance of a new prothrombin activating metalloprotease purified from Daboia russelii russelii venom.
Thakur R; Chattopadhyay P; Ghosh SS; Mukherjee AK
Toxicon; 2015 Jun; 100():1-12. PubMed ID: 25817001
[TBL] [Abstract][Full Text] [Related]
14. An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent medicine.
Du KZ; Cui Y; Chen S; Yang R; Shang Y; Wang C; Yan Y; Li J; Chang YX
J Ethnopharmacol; 2022 Apr; 287():114964. PubMed ID: 34990765
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
Rezaie AR
Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
[TBL] [Abstract][Full Text] [Related]
16. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide.
Hagemeyer CE; Tomic I; Jaminet P; Weirich U; Bassler N; Schwarz M; Runge MS; Bode C; Peter K
Thromb Haemost; 2004 Jul; 92(1):47-53. PubMed ID: 15213844
[TBL] [Abstract][Full Text] [Related]
17. Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
Wang W; Yuan J; Fu X; Meng F; Zhang S; Xu W; Xu Y; Huang C
Molecules; 2016 Apr; 21(4):491. PubMed ID: 27089317
[TBL] [Abstract][Full Text] [Related]
18. Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from Brevibacillus brevis strain FF02B.
Majumdar S; Sarmah B; Gogoi D; Banerjee S; Ghosh SS; Banerjee S; Chattopadhyay P; Mukherjee AK
Biochimie; 2014 Aug; 103():50-60. PubMed ID: 24735708
[TBL] [Abstract][Full Text] [Related]
19. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.
Branco VG; Iqbal A; Alvarez-Flores MP; Sciani JM; de Andrade SA; Iwai LK; Serrano SM; Chudzinski-Tavassi AM
Biochim Biophys Acta; 2016 Oct; 1864(10):1428-35. PubMed ID: 27479486
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
Prasa D; Svendsen L; Stürzebecher J
Thromb Haemost; 1997 Oct; 78(4):1215-20. PubMed ID: 9364987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
